Stay updated with breaking news from Three Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First time AI has been used to identify disease targets in RSVLONDON, UK / ACCESSWIRE / November 8, 2022 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF) ('Poolbeg' or the 'Company'), a clinical stage infectious
Poolbeg Pharma says its AI partner, OneThree Biotech, has completed the build and optimization of an AI model of Poolbeg's RSV data.
Further expansion of AI-based R&D Deal with Israeli firm to establish new R&D programme in influenza Poolbeg Pharma yesterday announced a deal with the...
Poolbeg Pharma artificial intelligence deal signed with OneThree Biotech
TRADING UPDATES: Enwell shuts down operations; i3 ups oil production | Financial News